.

ISSN 2063-5346
For urgent queries please contact : +918130348310

VALIDATION OF CHENOPODIUM LEAVES EXTRACTS PRIOR TO THE IMPLICATION OF NOOTROPIC ACTIVITY IN WISTAR RATS

Main Article Content

Vishesh Kumar Maurya*1,Rajveer Singh2, Km Pinki3,MohammadRizwan**4,TrishalaTripathi5, Dr.Vikas saxena6
» doi: 10.48047/ecb/2023.12.12.225

Abstract

accordance with the World Health Organisation (WHO), 80% of the population use herbal treatments for certain aspects of primary healthcare. As a consequence, natural products might constitute a new source of beneficial neuropsychotropic drugs if they undergo rigorous research and their mechanisms are accepted. Based on data from the World Health Organisation (WHO), 80% of the global population use botanical medicines for certain aspects of primary healthcare. As a result, natural products could be a new source of useful neuropsychotropic drugs if they undergo extensive research and their mechanisms are had comprehended. Alzheimer's disease is one of the most prevalent manifestations of dementia (50%). Cholinergic antagonism-induced cognitive declines mimic the cognitive hallmarks of Alzheimer's disease. The present work was under taken to evaluate the Nootropic activity of Chenopodium album leaves extracts in Scopolamine induce Alzhimer type Dementia in rats.For the purpose ethanolic & aqueous extract of Chenopodium album leaves were prepared and screened for phytochemical constituents and Nootropic activity.

Article Details